| abstract |
The present invention relates to conditions associated with metabolic disorders, postmenopausal obesity and high fat diet intake, eg obesity, weight gain, body fat formation, decreased bone mineral content, increased white adipose tissue weight, increased cholesterol levels, increased leptin levels, insulin To prevent and / or treat resistance, type 2 diabetes, elevated blood sugar levels, inflammatory diseases, cardiovascular diseases, fatty liver conditions (liver fat accumulation), uncoupling protein-1 (UCP-1) levels, and increased lipid synthesis. . |